tiprankstipranks

Michael J. Farrell Insider Profile

4 Followers
Michael J. Farrell, Chairman & CEO, Director at Resmed, holds 468.35K shares in Resmed (Ticker: RMD), holds 2.00K shares in Zimmer Biomet Holdings (Ticker: ZBH).
tipranks
Michael J. Farrell

Michael J. Farrell
Resmed (RMD)
Chairman & CEO, Director

Ranked #22,795 out of 109,030 Corporate Insiders

Profitable Transactions

73%
11 out of 15 Profitable Transactions

Average Return

+4.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$102M
99.82%
0.18%
A breakdown of Michael J. Farrell's holdings

Insider Roles

Resmed
(RMD)
Chairman & CEO, Director
Zimmer Biomet Holdings
(ZBH)
Director
Roles that Michael J. Farrell holds in companies

Most Profitable Insider Trade

Stock:
Resmed
(RMD)
Rating:Informative Sell
Date:Nov 14, 2022 - Nov 14, 2023
Return:+32.60%
The most profitable trade made by Michael J. Farrell

Michael J. Farrell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Resmed
Sep 10, 2026
Chairman & CEO, Director
Uninformative Sell
1.11M
$102.23M
Zimmer Biomet Holdings
Feb 14, 2019
Director
Informative Buy
247.24K
$186.98K
List of latest transactions for each holding click on a transaction to see Michael J. Farrell's performance on stock

Michael J. Farrell insider profile FAQ

What is the percentage of profitable transactions made by Michael J. Farrell?
The percentage of profitable transactions made by Michael J. Farrell is 73%.
    What is the average return per transaction made by Michael J. Farrell?
    The average return per transaction made by Michael J. Farrell is 4.80%.
      What stocks does Michael J. Farrell hold?
      Michael J. Farrell holds: RMD, ZBH stocks.
        What was Michael J. Farrell’s latest transaction?
        Michael J. Farrell latest transaction was an Uninformative Sell of $1.11M.
          What was Michael J. Farrell's most profitable transaction?
          Michael J. Farrell’s most profitable transaction was an Informative Sell of RMD stock on November 14, 2022. The return on the trade was 32.60%.
            What is Michael J. Farrell's role in Resmed?
            Michael J. Farrell's role in Resmed is Chairman & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.